Objectives-Particulate matter (PM) air pollution is associated with alterations in cardiac conductance and sudden cardiac death in epidemiological studies. Traffic-related air pollutants, including diesel exhaust (DE) may be at least partly responsible for these effects. In this experimental study we assessed whether short-term exposure to DE would result in alterations in heart rate variability (HRV), a non-invasive measure of autonomic control of the heart.
INTRODUCTION
Acute cardiovascular morbidity and mortality have been consistently associated with ambient fine particulate matter air pollution (PM 2.5 , particles with aerodynamic diameter 2.5μm or less) in epidemiological studies (Dominici, et al. 2006; Ostro, et al. 2007 ). PM-induced alterations in the balance of autonomic control of the heart may partly contribute to these associations. Recent epidemiological studies have demonstrated association between PM 2.5 and a shift of balance in the autonomic control of the heart (Liao, et al. 2004; Park, et al. 2005; Pope, et al. 2004; Romieu, et al. 2005) . These associations may be particularly strong for vehicle-related pollutants (Adar, et al. 2007; Riediker, et al. 2004; .
By mass, diesel exhaust (DE) is the primary source of vehicle-derived PM 2.5 (USEPA 2000) . DE is also a substantial contributor to poor air quality in urban environments, accounting for the majority of ultrafine particulate matter (<100 nm). These small particles have a very large surface area, are highly respirable and are excellent carriers for adsorbed inorganic and organic compounds. Therefore, we hypothesized that controlled exposure to DE would result in early alterations in heart rate variability (HRV) measured at 1 and 3 hours from the onset of exposure. Because previous studies have also shown effects of PM 2.5 on autonomic balance on the order of several hours to a day (Liao, et al. 1999; Park, et al. 2005) , we also explored the hypothesis that exposure to DE would effect HRV parameters measured at 6 and 22 hours from initiation of exposure.
METHODS
We conducted a double-blind crossover experiment of DE and filtered air (FA) exposures. In this experiment, each participant was exposed on three different days to each of three conditions: FA, DE calibrated to generate 100μg/m 3 of PM 2.5 (DE 100 ), and DE calibrated to generate 200μg/m 3 of PM 2.5 (DE 200 ). DE was derived from a 2002 model turbocharged directinjection 5.9 liter Cummins B-series engine (6BT5.9G6, Cummins, Inc., Columbus, IN). During exposures, PM 2.5 concentrations were continuously measured and adjusted to maintain steady-state conditions (TEOM 1400a PM 2.5 , Rupprecht & Patashnick Co., Albany, NY) (for a detailed description of the DE exposure system see the online data supplement. Exposures were randomized by order and separated in time by at least 2 weeks. All participants gave written informed consent. The University of Washington Human Subjects Division approved the consent form and study protocol.
Study participants
Recruited subjects were 18-49 years old with no history of ongoing medical care for heart disease, hypertension, asthma, diabetes, hypercholesterolemia, or other chronic conditions. All subjects were nonsmokers for at least six months and had normal spirometry. Since we were interested in susceptibility by disease status, we separately recruited "healthy" and "metabolic syndrome" participants. Healthy participants had a body mass index (BMI) below 30kg/m 2 , fasting blood sugar below 126mg/dL, resting blood pressure below 130/85 mmHg, and no signs of arrhythmia or ischemia on a screening electrocardiogram (ECG). Metabolic syndrome participants fulfilled any three of the following five criteria: waist circumference ≥102 cm in males and ≥ 88 cm in females; triglycerides ≥ 150 mg/dL; HDL cholesterol < 40 mg/dL in males and < 50 mg/dL in females; systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥ 85 mmHg; and fasting glucose ≥ 100 mg/dL. (Grundy, et al. 2005) 
Study protocol
Exposures began at 9am and were two hours in duration; participants were at rest throughout. We used a three-channel ambulatory Holter recorder (Del Mar, Irvine, CA, USA) to monitor continuous ECG tracings. The electrodes were placed in a modified V1-V5 position. ECG recordings started approximately 1 hour before the onset of exposures and continued throughout the exposure session days (~8-9 hours). ECG recordings were also collected over the entire duration of the follow-up visit (~1 hour) on the morning after exposure days.
Heart rate variability parameters
In order to prevent interference by participant activity, we limited the data for this analysis to standardized 10-minute periods during which subjects were resting supine. These resting periods were conducted at various time-points during the exposure day: before exposure started, at one hour into exposure (1h), and at three hours (3h), six hours (6h), and 22 hours (22h) from the onset of exposure. A single trained analyst, blinded to exposure levels, reviewed and edited the automatically determined readings of QRS complexes in these 10-minute intervals using Del Mar Dartscan software (Model DS-90, Irvine, CA, USA) to obtain all normal-normal (N-N) intervals. Any 10-minute recording with more than 10% ectopic beats and/or artifacts was excluded from the analysis.
For the analysis of HRV we used the middle five minutes of each 10-minute recording period, including only N-N intervals with a successive ratio within 0.8-1.2. We analyzed HRV using software created by The Biomedical Signal Analysis Group, Department of Applied Physics, University of Kuopio, Finland (Niskanen J-P 2004) . Generated time domain statistics included the standard deviation of N-N intervals (SDNN), and the square root of the mean squared differences between successive N-N intervals (RMSSD). For frequency domain analysis we used a Fast Fourier Transform (FFT) algorithm. The signal was analyzed with Hanning window for segment lengths of 256 samples with 50% overlapping (Singh, et al. 2004) . Spectral data obtained from N-N intervals were analyzed according to the following frequency bands: verylow frequency (VLF, 0.00-0.04 Hz), low frequency (LF, 0.04-0.15 Hz), and high frequency (HF, 0.15-0.40 Hz). Since very-low (and lower) frequency modulation of N-N interval data has no interpretable significance in short ECG recordings (Task-Force 1996), we report the frequency domain measures of LF and HF power in ms 2 , and the LF/HF ratio. To address any irregularity in the N-N interval time series, cubic interpolation at a rate of 4Hz was used before spectrum estimation. To remove the influence of a large low-frequency baseline trend component, a de-trending algorithm was used based on a smoothness priors method (Tarvainen MP 2002).
Statistical Analysis
All statistical testing was based on two-tailed tests with α =0.05. Descriptive data are presented as a mean ± standard error to the mean (SEM) unless specified otherwise. Statistical analyses were performed using STATA 9.1 (StataCorp LP, College Station TX).
All HRV parameters were log-transformed prior to statistical analysis as they were highly skewed. Changes in HRV were normalized as the difference between each HRV parameter at a given time-point after exposure onset relative to the same HRV parameter, pre-exposure. Exposure-related changes in HRV at each time point were computed for DE 200 or DE 100 by contrasting to the FA levels using paired t-tests. Due to our small study population, we computed the percent difference at 1h and 3h from the pre-exposure non-transformed levels of the HRV parameters that were significantly affected by DE exposure, to assess whether the effect was consistent among study participants. We also tested our results for effect modification by subject-related characteristics, and for period and carryover effects, using interaction terms in an ANOVA model.
RESULTS
A total of 23 participants (6 healthy and 17 metabolic syndrome) completed all three levels of exposure. Seven were excluded from further analyses: one participant did not meet the inclusion criteria for N-N intervals taken from the ECG measurement at pre-exposure to DE 200 ; six participants had missing ECG measurements at pre-exposure to either FA, or DE 200 . Characteristics of the 16 participants (3 healthy and 13 metabolic syndrome) with acceptable HRV measurements are presented in Table 1 .
The average exposure levels to PM 2.5 approximated the target concentrations. In addition, we maintain low concentrations of the gases carbon monoxide (CO) and nitrogen dioxide (NO2) ( Table 2) .
Pre-exposure HRV statistics were not significantly different between exposure sessions or between healthy and metabolic syndrome participants within exposure session (Table 3) . Although metabolic syndrome participants generally exhibited slightly lower HRV measures than healthy individuals within the same exposure session, we analyzed the DE effect on HRV statistics without sorting by health status due to the small number of healthy participants with available data. As a sensitivity analysis we also conducted analysis limited to the metabolic syndrome participants. Results were similar to those from both study populations combined.
Analysis of exposure-related changes of HRV parameters at all time periods are presented in Figure 1 . These results revealed no consistent differences at 1h between DE and FA. Table 4 shows the effect of exposure to DE 100 and DE 200 on HRV Parameters at 3h. While there was no significant effect for any HRV parameter from DE 100 , we noted a significant increase in HF power over pre-exposure levels after DE 200 (0.26) as compared to FA (-0.07) (Δ= 0.33; 95% CI: 0.01 to 0.7). At this same time-point, there was a decrease in LF/HF ratio from preexposure levels following DE 200 (-0.54) as compared to an increase after exposure to FA (0.2) (Δ= -0.74; 95% CI: -1.2 to -0.2).
Changes in the frequency domain HRV parameters observed at 3h remained generally consistent for DE 200 across the later time points with evidence of increased HF, decreased LF, and a decreased LF/HF ratio after DE as compared to FA (Figure 1) . At 22h following exposure to FA, frequency domain parameters showed a trend toward pre-exposure baseline values that was not observed after exposure to DE 200 . However, exposure-related changes in frequency domain statistics at 6h and 22h were not statistically different between exposures to DE 200 and FA. In addition, no dose response was observed in these later time points. No significant effect of DE was observed on heart rate (data not shown) and on time domain measurements at any time-points. Age, gender, BMI, fasting plasma lipid levels, smoking history, carryover, and period effects did not modify the association between DE and frequency domain statistics in all time points.
To assess whether the increased HF power was consistent among study participants, we plotted the percent difference of HF power from the pre-exposure level for each participant for both DE 200 and DE 100 at 1h and 3h (Figure A online data supplement). Only 7 (1 healthy and 6 metabolic syndrome) out of 16 participants showed an increased HF power at DE 200 as compared to FA. Six showed an increased HF at DE 100 as compared to FA. No consistent dose response relationship was observed. The same approach used for LF/HF ratio, revealed that only 9 out of 16 participants showed a decreased ratio at DE 200 as compared to FA.
DISCUSSION
In this study we did not find a consistent effect of DE inhalation on the autonomic modulation of the heart as assessed by heart rate variability measures. Although we showed a significant increment of HF power at 3h following DE 200 compared to FA, only 7 of 16 participants demonstrated this effect (supplementary Figure A) . No dose-response relationship was found for increasing concentrations of DE, and the effect was opposite of the most typically observed effect of air pollutants. Moreover, the significant decrease in LF/HF ratio at 3h following DE 200 compared to FA was driven by a small number of participants. Our inconsistent effect of DE on HF power and LF power does not allow inference regarding a shift in the balance of the autonomic control of the heart.
HRV has been used frequently in air pollution research as a signal of cardiovascular effect, and to explore for potential pathophysiological mechanisms by which air pollution may lead to cardiovascular mortality and morbidity. Epidemiological studies in susceptible populationsespecially panel study designs-have shown a relationship between air pollution and decreased HRV (Adar, et al. 2007; Chan, et al. 2004; Liao, et al. 1999; Liao, et al. 2004; Park, et al. 2005) as well as increased cardiac arrhythmia with exposure to components of ambient particulate air pollution (Dockery, et al. 2005; Peters, et al. 2000; Rich, et al. 2006; Sarnat, et al. 2006 ). The previously observed effects of air pollutants on HRV and arrhythmia are not entirely consistent across studies. Potential factors that may explain these discrepancies include age and health status of study participants, composition of particles and gases, and use of different methodologies for HRV analysis.
Compared to observational approaches such as panel study designs, an experimental approach as used in this study-with rigorous control over exposure situations and potentially confounding factors-would be expected to be highly tuned to finding an exposure-related effect if one exists. Our inability to find a decrease in HRV after DE inhalation in young individuals without known cardiovascular disease is consistent with prior controlled exposure studies to concentrated ambient particles (CAPS) (Devlin, et al. 2003; Gong, et al. 2004 ) and ultrafine carbon particles (Frampton, et al. 2004) . Moreover, while HRV was decreased in the lion's share of published epidemiological studies that involved elderly participants, HRV effects of air pollution in young healthy individuals did not consistently demonstrate this decline in HRV (Chan, et al. 2004; Devlin, et al. 2003; Frampton, et al. 2004; Gong, et al. 2004; Magari, et al. 2001; Riediker, et al. 2004; Scharrer, et al. 2007 ). It has long been recognized that autonomic function changes with increasing age, as demonstrated by a decrease in HRV even in individuals without preexisting cardiovascular or autonomic disease (Liao, et al. 1995; O'Brien, et al. 1986 ). It is possible that the response of the autonomic nervous system to a stimulus such as pollutant inhalation may be different between elders who are healthy or possess underlying unknown cardiovascular disease and our study population. Although our population included individuals with metabolic syndrome, the absence of pre-existing cardiovascular disease or autonomic neuropathy in our population may decrease the utility of HRV measures. The significant range of HRV responses in routine cardiac modulation in our study population may have overwhelmed the small adverse DE effect on autonomic modulation.
The composition of the inhaled pollutants may also contribute to the discordance of our findings with previously published data. DE is not the only source of pollution and co-pollutants such as ozone may potentially make diesel particles more injurious to biological tissues (Bosson, et al. 2007; Madden, et al. 2000) . Therefore, although our system creates a realistic combustionderived exposure, which is highly relevant to urban air pollution, especially traffic-related exposure, it may not replicate the situations seen in observational studies of HRV.
The different methods of HRV analyses in prior air pollution studies (long-term (24 hours) (Adar, et al. 2007; Magari, et al. 2002; Pope, et al. 2004; Pope, et al. 1999 ) and short-term (5 minutes)) (Devlin, et al. 2003; Frampton, et al. 2004; Gong, et al. 2004; Liao, et al. 2004; Park, et al. 2005; Sullivan, et al. 2005) can lead to different inferences for PM effect on HRV (Task-Force 1996). To allow for maximal comparability between exposures, we opted for short-term standardized HRV analysis rather than long-term analysis, thus eliminating influence by factors such as variation in posture, physical and mental activity, and sleep. As a result, our results cannot be compared directly to all other published studies of HRV and pollution.
The timing of outcome assessments also differs between studies, and reflects uncertainty regarding the time course of the cascade of effects which might culminate in the health effects of PM. While PM appear to exert health effects within hours of exposure (Mills, et al. 2005; Peters, et al. 2001) , we sought to find early effects of DE on HRV. Alternatively, PM exposure may lead to an initial pulmonary inflammatory response with subsequent cascade of delayed effects (hours or even days) on the autonomic nervous system (Haefeli, et al. 1993; Nel, et al. 2001; van Eeden, et al. 2001; Weisensee, et al. 1993 ). We did not demonstrate a late effect of DE on HRV; however, we noticed long-term trends in frequency domain parameters compared to pre-exposure values. Although this trend lacked statistical significance, it may represent the onset of a late autonomic effect. In fact, Park et al. demonstrated the strongest effect on HRV (decreased HRV) was with a 48-hour moving average of PM 2.5 (Park, et al. 2005) . If future experimental studies are conducted, it would be prudent to explore late autonomic effects.
Strengths and limitations
This study's strength is in the experimental design, unlike most published studies that have used an observational design from which it is much more difficult to determine causal relationships. Nonetheless, several limitations may hinder inference from this study. First, after applying our exclusion criteria on HRV data, only a small and nonhomogenous study population was analyzed. We did not find significant baseline differences in HRV statistics between the two sub-populations of the study. Second, we assessed HRV in short recording intervals. This may have affected our ability to identify any difference in time domain statistics between the exposure sessions (Task-Force 1996) , and we may have sacrificed some power to detect associations by limiting the number of outcome measures in our dataset. In addition, this approach may have limited our ability to directly compare our results with those of other studies.
CONCLUSIONS
In a controlled exposure experiment, we were not able to show a consistent effect of diesel exhaust inhalation on heart rate variability. To better understand and confirm prior observations of PM effects on HRV principally derived from non-experimental designs, controlled exposure experimental studies in different susceptible populations, using relevant exposures and standardized analysis of ECG recordings, are needed.
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